ACTIVE

KYTOS

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result
136,7 k €
+2 434,6 %over 1 year
Gross margin
345,4 k €
+55,1 %over 1 year
Equity
535,6 k €
+34,3 %over 1 year
Workforce
3,3 ETP
-5,7 %over 1 year

Identity

Source · BCE/KBO

KYTOS is a Private limited company incorporated in 2021. Its main activity is: Other information technology and computer service activities. Its registered office is in Gent. It employs on average 3,3 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0768.755.286
Incorporation
26/05/2021
Legal form
Private limited company
Registered office
Technologiepark-Zwijnaarde 82
9052 Gent · FlandreSee on map
Contributed capital
31 764,70 €
Latest accounts
31/12/2025
Average workforce
3,3 ETP
Joint committees (4)
  • 100
  • 1000
  • 200
  • 2000
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 4 filings

Trend over 4 financial years

2025202420232022
Income statement
Gross margin345,4 k €222,7 k €313,4 k €276,9 k €
EBITDA152,1 k €17,1 k €168,8 k €208,3 k €
Operating result143,1 k €9,5 k €165,3 k €207,7 k €
Net result136,7 k €5,4 k €163,9 k €197,9 k €
Balance sheet
Equity535,6 k €398,9 k €393,6 k €229,7 k €
Total assets920,7 k €770,3 k €812,3 k €531 k €
Cash549,8 k €415 k €283,4 k €188 k €
Debts280,2 k €214 k €124,4 k €82,9 k €
Other
Workforce3,3 ETP3,5 ETP2,6 ETP1,3 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 5 ended

Active mandates

Marc Indigne

Director · since 26 mai 2021 · until 30 juin 2028

Active
Nico Boon

Director · since 26 mai 2021 · until 30 juin 2026

Active
Ruben Props

Director · since 26 mai 2021 · until 30 juin 2029

Active
Synidrytis

Director · since 26 mai 2021 · until 30 juin 2029 · 0768.580.686

Represented by Frederiek-Maarten Kerckhof

Active

Ended mandates

Marc Indigne

Director · since 26 mai 2021 · until 02 juin 2026

Ended
Marc Johan Octave Indigne

Director · since 26 mai 2021 · until 02 juin 2026

Ended
Nico Boon

Director · since 26 mai 2021 · until 02 juin 2026

Ended
Ruben Props

Director · since 26 mai 2021 · until 02 juin 2026

Ended

Other companies at this address

Technologiepark-Zwijnaarde 82 9052 Gent
CompanyCBE no.
Amalus Therapeutics● Bankrupt
0803.929.268
APCOR R&M● Active
0600.952.909
Ardoyen● Active
0875.102.821
AVROXA● Active
0687.774.936
Benebiose● Active
0784.521.548
BioNeering● Active
0807.194.309
CONTREL EUROPE● Active
0426.204.637
CRODEON TECHNOLOGIES● Active
0642.754.761
Cryptobiotix● Active
0762.565.104
Gulliver Biomed● Active
0692.527.837
ImplicitMeasures.com● Bankrupt
0657.989.701
Inbiose● Active
0534.887.593
INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT● Active
0440.054.752
INNOVATIVE PHARMACEUTICS● Active
0883.574.582
Inspect● Active
0645.950.417
INVIBES ADVERTISING● Active
0836.533.938
Lares Solutions● Active
1015.346.906
MAYAKU PHARMACEUTICAL DEVELOPMENT● Active
0755.350.975
Microbial Resource Management Health● Active
0742.910.132
Microbial Resource Management Technologies● Active
0667.765.816

Full financial information

Source · NBB
2025202420232022
Type of accountAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202326/05/2021
Closing of the financial year31/12/202531/12/202431/12/202331/12/2022
Length of the financial year12 months12 months12 months20 months
Filing date22/07/202624/07/202503/07/202422/06/2023
General meeting30/06/202630/06/202504/06/202406/06/2023
Currency of the financial yearEUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 4 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202530/06/202622/07/2026DutchPDF
Abridged model31/12/202430/06/202524/07/2025DutchPDF
Abridged model31/12/202304/06/202403/07/2024DutchPDF
Abridged model31/12/202206/06/202322/06/2023DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 5 ended

Active mandates

Marc Indigne

Director · since 26 mai 2021 · until 30 juin 2028

Active
Nico Boon

Director · since 26 mai 2021 · until 30 juin 2026

Active
Ruben Props

Director · since 26 mai 2021 · until 30 juin 2029

Active
Synidrytis

Director · since 26 mai 2021 · until 30 juin 2029 · 0768.580.686

Represented by Frederiek-Maarten Kerckhof

Active

Ended mandates

Marc Indigne

Director · since 26 mai 2021 · until 02 juin 2026

Ended
Marc Johan Octave Indigne

Director · since 26 mai 2021 · until 02 juin 2026

Ended
Nico Boon

Director · since 26 mai 2021 · until 02 juin 2026

Ended
Ruben Props

Director · since 26 mai 2021 · until 02 juin 2026

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates21/08/2026
    ONTSLAG - HERBENOEMING - VOLMACHT
    PDF
  • Other28/05/2021
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025136,7 k €↑
  2. 2024
    Annual accounts 20245,4 k €↓
  3. 2023
    Annual accounts 2023163,9 k €↓
  4. 2022
    Annual accounts 2022197,9 k €
  5. 26/05/2021
    IncorporationPrivate limited company